Pros | Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 8/8 | 1/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 6 Years | 7 Years | ||
Fund Size | 854 Cr | 6460 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹1000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 1.03% | 1.03% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 38 | 44 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (11.6%) Apollo Hospitals Enterprise Ltd (7.7%) Cipla Ltd (6.68%) Fortis Healthcare Ltd (4.56%) Lupin Ltd (4.55%) | Sun Pharmaceuticals Industries Ltd (11.88%) Dr Reddy's Laboratories Ltd (9.42%) Divi's Laboratories Ltd (8.5%) Aurobindo Pharma Ltd (7.62%) Cipla Ltd (6.61%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (99.05%) Basic Materials (0.95%) | Health (97.59%) Basic Materials (1.21%) Financial Services (1.2%) | ||
Equity % | 96.74% | 97.1% | ||
Debt % | - | - | ||
P/E | 37.58 | 31.48 | ||
P/B | 5.51 | 4.31 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -1.34% | -0.89% | ||
3-Month Return | -1.54% | -1.03% | ||
6-Month Return | 1.86% | 2.14% | ||
1-Year Return | 0.92% | 5.17% | ||
3-Year Return | 22.27% | 28.37% | ||
5-Year Return | 15.83% | 19.48% |
Sharpe | 0.93 | 1.25 | ||
Alpha | -0.97 | 3.97 | ||
Beta | 0.96 | 0.95 | ||
Standard Deviation | 16.06 | 15.7 | ||
Information Ratio | -0.51 | 1.26 |
Description | Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhaval Shah | Dharmesh Kakkad,Sharmila D’mello |